Francisco J. Esteva: The potential of integrating physical activity into treatment protocols

Francisco J. Esteva, Chief, Division of Hematology and Medical Oncology at Lenox Hill Hospital shared a post on LinkedIn:

“Moderate physical activity during neoadjuvant chemotherapy in breast cancer patients has been shown to reduce inflammation and increase pathological complete response rates, according to the Neo-Runner study. This important finding underscores the potential of integrating physical activity into treatment protocols to improve patient outcomes.”

Moderate physical activity during neoadjuvant chemotherapy in breast cancer patients: effect on cancer-related inflammation and pathological complete response-the Neo-Runner study

Autors: O Garrone, M Paccagnella, A Abbona, F Ruatta, P Vanella, N Denaro, G Tomasello, N Croce, F Barbin, M G Rossino, C A M La Porta, A Sapino, V Torri, A Albini, M C Merlano

Source: Francisco J. Esteva/LinkedIn